BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26232371)

  • 1. Parsimonious Description of Glucose Variability in Type 2 Diabetes by Sparse Principal Component Analysis.
    Fabris C; Facchinetti A; Fico G; Sambo F; Arredondo MT; Cobelli C;
    J Diabetes Sci Technol; 2015 Jul; 10(1):119-24. PubMed ID: 26232371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sparse Principal Component Analysis for the parsimonious description of glucose variability in diabetes.
    Fabris C; Facchinetti A; Sparacino G; Cobelli C
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():6643-6. PubMed ID: 25571519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose variability indices in type 1 diabetes: parsimonious set of indices revealed by sparse principal component analysis.
    Fabris C; Facchinetti A; Sparacino G; Zanon M; Guerra S; Maran A; Cobelli C
    Diabetes Technol Ther; 2014 Oct; 16(10):644-52. PubMed ID: 24956070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple Linear Support Vector Machine Classifier Can Distinguish Impaired Glucose Tolerance Versus Type 2 Diabetes Using a Reduced Set of CGM-Based Glycemic Variability Indices.
    Longato E; Acciaroli G; Facchinetti A; Maran A; Sparacino G
    J Diabetes Sci Technol; 2020 Mar; 14(2):297-302. PubMed ID: 30931604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and Prediabetes Classification Using Glycemic Variability Indices From Continuous Glucose Monitoring Data.
    Acciaroli G; Sparacino G; Hakaste L; Facchinetti A; Di Nunzio GM; Palombit A; Tuomi T; Gabriel R; Aranda J; Vega S; Cobelli C
    J Diabetes Sci Technol; 2018 Jan; 12(1):105-113. PubMed ID: 28569077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose Variability: A Review of Clinical Applications and Research Developments.
    Rodbard D
    Diabetes Technol Ther; 2018 Jun; 20(S2):S25-S215. PubMed ID: 29916742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The continuous spectrum of glycaemic variability changes with pancreatic islet function: A multicentre cross-sectional study in China.
    Zhang L; Guo K; Tian Q; Ye J; Ding Z; Zhou Q; Wu J; Fan L; Pan N; Niu X; Zhao Q; Ma Y; Jiang H; Huang G; Li X; Zhou Z; Yang L
    Diabetes Metab Res Rev; 2022 Nov; 38(8):e3579. PubMed ID: 36214297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose Variability Assessed with Continuous Glucose Monitoring: Reliability, Reference Values, and Correlations with Established Glycemic Indices-The Maastricht Study.
    Foreman YD; Brouwers MCGJ; van der Kallen CJH; Pagen DME; van Greevenbroek MMJ; Henry RMA; Koster A; Wesselius A; Schaper NC; Stehouwer CDA
    Diabetes Technol Ther; 2020 May; 22(5):395-403. PubMed ID: 31886732
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycaemic variability-based classification of impaired glucose tolerance vs. type 2 diabetes using continuous glucose monitoring data.
    Longato E; Acciaroli G; Facchinetti A; Hakaste L; Tuomi T; Maran A; Sparacino G
    Comput Biol Med; 2018 May; 96():141-146. PubMed ID: 29573667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes.
    Chan CL
    Curr Diab Rep; 2017 Sep; 17(9):66. PubMed ID: 28726154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are Risk Indices Derived From CGM Interchangeable With SMBG-Based Indices?
    Fabris C; Patek SD; Breton MD
    J Diabetes Sci Technol; 2015 Aug; 10(1):50-9. PubMed ID: 26275643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Should We Assess Glycemic Variability in Type 1 Diabetes? Contribution of Principal Component Analysis for Interstitial Glucose Indices in 142 Children.
    Guilmin-Crépon S; Carel JC; Schroedt J; Scornet E; Alberti C; Tubiana-Rufi N
    Diabetes Technol Ther; 2018 Jun; 20(6):440-447. PubMed ID: 29923773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between glucose variability and conventional measures of glycemic control in continuously monitored patients with type 2 diabetes.
    Kohnert KD; Vogt L; Augstein P; Heinke P; Zander E; Peterson K; Freyse EJ; Salzsieder E
    Horm Metab Res; 2009 Feb; 41(2):137-41. PubMed ID: 19214924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose Variability: Comparison of Different Indices During Continuous Glucose Monitoring in Diabetic Patients.
    Le Floch JP; Kessler L
    J Diabetes Sci Technol; 2016 Jul; 10(4):885-91. PubMed ID: 26880391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a New Measure for Assessing Glucose Monitoring Device-Related Treatment Satisfaction and Quality of Life.
    Polonsky WH; Fisher L; Hessler D; Edelman SV
    Diabetes Technol Ther; 2015 Sep; 17(9):657-63. PubMed ID: 25923812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Daily Glycemic Variability in Subjects with Type 1 Diabetes Using a Mixture of Metrics.
    Zheng F; Jalbert M; Forbes F; Bonnet S; Wojtusciszyn A; Lablanche S; Benhamou PY
    Diabetes Technol Ther; 2020 Apr; 22(4):301-313. PubMed ID: 31657620
    [No Abstract]   [Full Text] [Related]  

  • 18. Retrofitting of continuous glucose monitoring traces allows more accurate assessment of glucose control in outpatient studies.
    Del Favero S; Facchinetti A; Sparacino G; Cobelli C;
    Diabetes Technol Ther; 2015 May; 17(5):355-63. PubMed ID: 25671379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Frequency Domain of Continuous Glucose Monitoring Signals to Improve Characterization of Glucose Variability and of Diabetic Profiles.
    Fico G; Hernández L; Cancela J; Isabel MM; Facchinetti A; Fabris C; Gabriel R; Cobelli C; Arredondo Waldmeyer MT
    J Diabetes Sci Technol; 2017 Jul; 11(4):773-779. PubMed ID: 28627250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application.
    Kovatchev BP; Clarke WL; Breton M; Brayman K; McCall A
    Diabetes Technol Ther; 2005 Dec; 7(6):849-62. PubMed ID: 16386091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.